Manoussakis M N, Dimitriou I D, Kapsogeorgou E K, Xanthou G, Paikos S, Polihronis M, Moutsopoulos H M
School of Medicine, National University of Athens, Greece.
Arthritis Rheum. 1999 Feb;42(2):229-39. doi: 10.1002/1529-0131(199902)42:2<229::AID-ANR4>3.0.CO;2-X.
To investigate the expression of B7 costimulatory molecules in the lymphoepithelial lesions of salivary gland (SG) biopsy tissues and in SG epithelial cell lines derived from patients with Sjögren's syndrome (SS).
B7.1 and B7.2 protein expression was studied by immunohistochemistry in minor SGs obtained from 11 patients with SS and 10 disease control patients with nonspecific sialadenitis and in cultured SG epithelial cell lines obtained from minor SGs from 15 SS patients and 15 control patients. B7.1 and B7.2 messenger RNA (mRNA) expression by SG epithelial cell lines was examined by reverse transcription-polymerase chain reaction (RT-PCR).
In biopsy tissues from SS patients, but not control patients, ductal and acinar epithelial cells showed increased expression of both B7.1 and B7.2. Intense spontaneous B7.1 protein expression (as well as HLA-ABC, but not B7.2 or HLA-DR) was also found in 73% of SG epithelial cell lines from SS patients versus 13% of those from control patients (P < 0.01). Interferon-y treatment induced, or up-regulated, B7.1, B7.2, and HLA-DR expression in all SG epithelial cell lines tested. B7.1 and B7.2 expression by SG epithelial cell lines was also verified at the mRNA level by RT-PCR.
Human SG epithelia are intrinsically capable of expressing B7 proteins upon activation. In SS patients, the expression of B7 molecules by SG epithelial tissues and by SG epithelial cell lines indicates the activated status of SG epithelial cells in this disorder and, possibly, their capacity for presenting antigens to T cells.
研究B7共刺激分子在干燥综合征(SS)患者唾液腺(SG)活检组织的淋巴上皮病变以及SG上皮细胞系中的表达情况。
采用免疫组织化学方法研究11例SS患者和10例非特异性涎腺炎疾病对照患者的小唾液腺中B7.1和B7.2蛋白的表达,以及从15例SS患者和15例对照患者的小唾液腺中获取的培养SG上皮细胞系中B7.1和B7.2蛋白的表达。通过逆转录聚合酶链反应(RT-PCR)检测SG上皮细胞系中B7.1和B7.2信使核糖核酸(mRNA)的表达。
在SS患者的活检组织中,导管和腺泡上皮细胞中B7.1和B7.2的表达均增加,而对照患者中未出现这种情况。在SS患者的SG上皮细胞系中,73%的细胞出现强烈的自发B7.1蛋白表达(以及HLA-ABC,但不包括B7.2或HLA-DR),而对照患者的细胞系中这一比例为13%(P<0.01)。干扰素-γ处理可诱导或上调所有测试的SG上皮细胞系中B7.1、B7.2和HLA-DR的表达。RT-PCR也在mRNA水平验证了SG上皮细胞系中B7.1和B7.2的表达。
人SG上皮细胞在激活后具有内在表达B7蛋白的能力。在SS患者中,SG上皮组织和SG上皮细胞系中B7分子的表达表明该疾病中SG上皮细胞的激活状态,以及它们可能具有向T细胞呈递抗原的能力。